Healthcare - Biotechnology - NASDAQ - US
$ 6.175
-10.6 %
$ 1.73 B
Market Cap
-4.23
P/E
Price Target
Average
82.19%
Revenue Forecast
Estimate
44.49%
EBIT
Estimate
13.69%
Net Income
Estimate
11.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Recursion Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RXRX of $11.2 , with forecasts ranging from a low of $6 to a high of $16 .
RXRX Lowest Price Target
Wall Street Target
6 USD
-2.83%
RXRX Average Price Target
Wall Street Target
11.2 USD
82.19%
RXRX Highest Price Target
Wall Street Target
16 USD
159.11%
REVENUE FORECAST
Revenue Forecast Chart RXRX
EBIT FORECAST
EBIT Forecast Chart RXRX
NET INCOME FORECAST
Net Income Chart RXRX